08/28/2026
Space-based biomanufacturing is moving closer to commercial reality, and LambdaVision is part of the story.
We’re proud to see LambdaVision and CEO Nicole Wagner, Ph.D., featured alongside leaders across the industry. The article highlights our nine missions to the International Space Station National Laboratory, the advantages we’ve observed manufacturing our artificial retinas in microgravity, and our plans to expand to new orbital platforms.
Thank you to Michael Greshko for taking a closer look at the opportunities, and challenges, shaping this emerging industry.
Read more: https://www.science.org/content/article/dreams-making-drugs-and-tissues-space-get-closer-reality
Maturing techniques and cheaper launches fuel microgravity research—and hopes of orbital manufacturing